Longboard Pharmaceuticals, Inc. (LBPH)
NASDAQ: LBPH · IEX Real-Time Price · USD
35.95
-0.05 (-0.14%)
At close: Jul 19, 2024, 4:00 PM
36.00
+0.05 (0.14%)
Pre-market: Jul 22, 2024, 8:00 AM EDT
Longboard Pharmaceuticals Employees
Longboard Pharmaceuticals had 50 employees as of December 31, 2023. The number of employees increased by 17 or 51.52% compared to the previous year.
Employees
50
Change (1Y)
17
Growth (1Y)
51.52%
Revenue / Employee
n/a
Profits / Employee
-$1,159,040
Market Cap
1.40B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 50 | 17 | 51.52% |
Dec 31, 2022 | 33 | 11 | 50.00% |
Dec 31, 2021 | 22 | 16 | 266.67% |
Dec 31, 2020 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Brookdale Senior Living | 36,000 |
U.S. Physical Therapy | 6,720 |
Phreesia | 1,438 |
Indivior | 1,164 |
Vir Biotechnology | 587 |
BioCryst Pharmaceuticals | 536 |
Dynavax Technologies | 408 |
Nurix Therapeutics | 284 |
LBPH News
- 18 days ago - Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
- 18 days ago - Top 3 Health Care Stocks That May Crash This Quarter - Benzinga
- 20 days ago - Longboard Pharmaceuticals Receives Breakthrough Therapy Designation for Bexicaserin (LP352) - Business Wire
- 5 weeks ago - Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs) - Business Wire
- 2 months ago - Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates - Business Wire
- 3 months ago - Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15 - Business Wire
- 4 months ago - Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates - Business Wire
- 6 months ago - Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February - Business Wire